Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice by Andrea Di Lenarda, Nicola Ferri, Massimiliano Lanzafame, Eva Agostina Montuori, Luciano Pacelli

Get full text

Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records. by Giulia Barbati, Caterina Gregorio, Arjuna Scagnetto, Carla Indennidate, Chiara Cappelletto, Andrea Di Lenarda

Get full text

Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI by Leonardo De Luca, Furio Colivicchi, Domenico Gabrielli, Donata Lucci, Gabriele Grippo, Francesco Piemonte, Bruno Villari, Andrea Di Lenarda, Fabrizio Oliva, Michele Massimo Gulizia

Get full text

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes? by Leonardo Bolognese, Andrea Rubboli, Leonardo De Luca, Donata Lucci, Domenico Gabrielli, Andrea Di Lenarda, Michele Massimo Gulizia, Massimo Uguccioni, Simonetta Blengino, Jeness Campodonico, Ilaria Meynet, Silvia Maria Brach Prever

Get full text